Savage Brian
Insider CIK 2112339 · TEVA Interim Chief Legal Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-09-18 | 2026-09-22 | 4,503 | $34.70 | $156.3K | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-09-18 | 2026-09-22 | 4,503 | $34.70 | $156.3K | 15,842 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-09-18 | 2026-09-22 | 4,503 | $38.69 | $174.2K | 11,339 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-09-18 | 2026-09-22 | 2,525 | $39.15 | $98.9K | 8,814 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-09-18 | 2026-09-22 | 314 | $38.70 | $12.2K | 8,500 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-09-18 | 2026-09-22 | 4,503 | $34.70 | $156.3K | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-09-18 | 2026-09-22 | 314 | $38.70 | $12.2K | 8,500 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-09-18 | 2026-09-22 | 2,525 | $39.15 | $98.8K | 8,814 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-09-18 | 2026-09-22 | 4,503 | $38.69 | $174.2K | 11,339 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-09-18 | 2026-09-22 | 4,503 | $34.70 | $156.3K | 15,842 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-05 | 2026-03-09 | 3,580 | — | $0 | 10,740 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-03-05 | 2026-03-09 | 1,127 | $31.67 | $35.7K | 10,914 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-05 | 2026-03-09 | 3,580 | — | $0 | 12,041 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2026-03-04 | 2026-03-06 | 11,280 | — | $0 | 11,280 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-04 | 2026-03-06 | 4,744 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-04 | 2026-03-06 | 3,766 | — | $0 | 7,534 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-04 | 2026-03-06 | 3,466 | — | $0 | 9,647 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-03-04 | 2026-03-06 | 1,489 | $32.46 | $48.3K | 6,181 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-04 | 2026-03-06 | 4,744 | — | $0 | 7,670 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-03-04 | 2026-03-06 | 1,186 | $32.46 | $38.5K | 8,461 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-03 | 2026-03-05 | 3,461 | — | $0 | 3,461 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-03-03 | 2026-03-05 | 1,274 | $32.36 | $41.2K | 2,926 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-03 | 2026-03-05 | 3,461 | — | $0 | 4,200 | SEC↗ |